CVE-2026-50034

CVE-2026-50034 is a medium-severity vulnerability with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-319.

Key facts

Description

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

Frequently asked questions

What is CVE-2026-50034?
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
How severe is CVE-2026-50034?
CVE-2026-50034 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2026-50034 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (4th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2026-50034?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-50034 have an EU (EUVD) identifier?
Yes. CVE-2026-50034 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-37971.
When was CVE-2026-50034 published?
CVE-2026-50034 was published on 2026-06-19 and last updated on 2026-06-22.

References

Other CWE-319 (Cleartext Transmission of Sensitive Information) vulnerabilities

Browse all CWE-319 (Cleartext Transmission of Sensitive Information) vulnerabilities →